BMO Capital raised the firm’s price target on Healthcare Services (HCSG) to $22 from $20 and keeps a Market Perform rating on the shares. Q4 revenue was in line but adjusted EBITDA beat consensus by 22% on stronger than expected margins, as the company guided to mid-single-digit 2026 revenue growth following 7% in 2025, driven by improved earnings consistency, better cash collections, and momentum in the Campuses end-market, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
